— Deutsche Bank hiked its price target on Apple to $400 per share from $380 per share, implying a 7.3% upside from Tuesday's close of $372.69. "Overall, we feel comfortable that AAPL should continue to offer upside for investors," a Deutsche Bank analyst said in a note.
However, the analyst noted the stock's recently sharp run-up "has us nervous." — Biogen shares jumped nearly 7% after the company submitted an application to the Food and Drug Administration for aducanumab as a treatment for Alzheimer's disease. "If approved, aducanumab would be the first treatment with the potential to meaningfully change the course of Alzheimer's disease," Biogen said in a release.
Anyone notice the same trend about Stocks StockMarket that the rest of us do? The economic reports are strong , stocks are trying to recover, even a significant barometer of economic recovery - the airline stocks are FINALLY starting to recover and CNBC is negative reporting!
Ask the ADL spokesman if their coalition supports removing any BLM ref to Facebook since their platform supports anti-semetic and anti-Israel speech.
Question for CNBC: maybe in between stonk promoting you can have someone answer this... When will the Fed pull the plug on this Stonk Party and what will happen if the GOV takes away the 600$ a week bonus for unemployment. Thank you
Looks like Apple must have closed more stores for the stock to be up. 🤣
Belgique Dernières Nouvelles, Belgique Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »
La source: CNBC - 🏆 12. / 72 Lire la suite »